UK Court Affirms Invalidity Of Gene Patent In Lilly Suit

Law360, New York (February 09, 2010, 4:22 PM ET) -- In one of the first British cases to deal with the limits of the utility requirement for biotech patents, a U.K. appeals court has struck down a Human Genome Sciences Inc. patent for a gene sequence in a dispute with Eli Lilly and Co.

The appeals court ruling Tuesday upheld a lower court decision finding the patent invalid for lack of industrial application, despite a December ruling from an appeal board at the European Patent Office that the same patent was valid.

The dispute centers around...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required